Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_assertion type Assertion NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_head.
- NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_assertion description "[We have examined the relationship of lipid peroxidation (thiobarbituric acid-reactive substances; TBARS) and antioxidant capacity (Trolox-equivalent) to APOE status, Braak tangle stage, amyloid-? (A?) plaque load, and the concentration of soluble and insoluble forms of A?, post-synaptic and dendritic spine proteins PSD95 and drebrin, ?-secretase and A?-degrading enzymes neprilysin (NEP), insulin-degrading enzyme (IDE), and angiotensin-converting enzyme (ACE), in frontal, temporal, and parietal cortex from AD and control brains.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_provenance.
- NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_assertion evidence source_evidence_literature NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_provenance.
- NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_assertion SIO_000772 20930272 NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_provenance.
- NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_assertion wasDerivedFrom befree-20140225 NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_provenance.
- NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_assertion wasGeneratedBy ECO_0000203 NP897558.RAD_MuH18G6G4rUHmd2ZbsX74X1rG_6ZL56Oza9C4pn0Y130_provenance.